Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 21 results found. Search for [ paras pharma ]

Results 1 to 21 of 21
May 21, 2020
Coronavirus lockdown 4.0 India highlights: Delhi reported the highest single-day spike of 571 fresh cases on Thursday, taking tally in the city to 11,659 and the death toll from coronavirus infection rose to 194

August 26, 2019

January 25, 2019
The BSE benchmark Sensex gave up initial gains Friday and closed 169 points lower at 36,025.54 as shares of Maruti Suzuki cracked after weak Q3 earnings, offsetting gains in Yes Bank, HDFC, ITC and TCS.

January 24, 2019

January 24, 2019
During the session, the BSE benchmark Sensex swung over 260 points both ways on alternate bouts of buying and selling by participants.

January 22, 2019

January 21, 2019

January 17, 2019

PB Jayakumar
New Delhi, January 16, 2018
Pegged at over Rs 18,862 crore by a Nicholas Hall 2017 report, the Indian OTC market is expected to grow at a compounded annual growth rate (CAGR) of 9 percent to cross Rs 44,115 crore.

Shamni Pande
April 24, 2014
Former Paras Pharma co-promoter lines up distinct strategies in FMCG and in healthcare.

Shamni Pande
Delhi, May 3, 2014
Patel's growing reputation as a brand wizard has caught the attention of investors. Sequoia Capital pumped in Rs 110-crore into Vini in August 2013 for a 9 per cent stake.

New Delhi, January 2, 2014
Stock markets are likely to remain upbeat in 2014 after modest gains in the last year, experts say, while putting across a particularly bullish outlook for sectors like IT and pharmaceuticals.
July 16, 2013
The survey aims to provide feedback to companies on what the employee marketplace thinks of them, which qualities in a company are considered important by employees, which factors attract people, which demoralise them, etc.

Shamni Pande
May 22, 2012
When feisty Indian brands roll up their sleeves, it's time for MNCs to worry. Business Today presents a selection of small, regional brands that have been around for years, and are drawing up aggressive plans that should have the big names in the business worried. SUCCESS STORY OF DESI BRANDS Vi-John | Havmor | Sakthi Masala | Mapro | Dantadhavanachoornam | Sosyo | Wagh Bakri |  Kalimark

New Delhi, February 15, 2012
While the financial details of the latest transaction were not disclosed, Reckitt in April 2011 had paid Rs 3,260 crore for acquisition of home-grown Paras Pharmaceuticals.
February 14, 2012
Backing spunky entrepreneurs is once again Sequoia Capital India's mantra.

Mumbai, April 14, 2011
The company had, in December last, announced that it will acquire Paras, the maker of brands such as Moov, Krack and D'cold, for Rs 3,260 crore.

Manu Kaushik
February 9, 2011
FMCG companies are tapping opportunities in the growing consumer healthcare market, one of the many categories that blur the distinction between fast-moving consumer goods and pharmaceuticals.

Kolkata, December 20, 2010
Emami's bid was turned down in favour of Reckitt Benckiser, which had submitted a bid of Rs 3,260 crore for the acquisition of Paras Pharmaceuticals.

New Delhi, December 13, 2010
As part of the deal, Reckitt will buy 63 per cent stake of emerging markets private equity investor Actis, Sequoia Capital and that of the remaining shareholders.

PAGES 1 OF 2  12